Logo

Virtus LifeSci Biotech Products ETF

BBP

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.‏‏‎ ‎

-

ETF

Equity

- years

198 holdings

Price

per share adjusted in USD

$67.53

Price

+1.28%

$0.86

Market Cap

$24.953m

Small

$1.935k

Avg Volume
Assets Under Management

$20.885m

$60.11

NAV

0.79%

Expense Ratio

Dividends

Ex-Dividend: -

0.00%

Yield

$0.00

Dividend

Dividends

Dividend history
No items found.
Yield
Benchmark
Sectors
Top 100 Holdings
↑ TopSummaryPriceDividendsHoldings